Adverse Events (Aes) as Potential Predictive Factors of Activity in Patients with Advanced Hepatocellular Carcinoma (Hcc) Treated with Atezolizumab plus Bevacizumab (Ab)

AuthID
 P-00Z-QQW
20
Author(s)
Rimini, M
·
Tada, T
·
Suda, G
·
Shimose, S
·
Kudo, M
·
Yoo, C
·
Cheon, J
·
Lim, HY
·
Presa, J
·
Bergamo, F
·
Iavarone, MA
·
Foschi, FG
·
Piscaglia, F
·
Gardini, AC
Document Type
Abstract
Year published
2023
Published
in ANNALS OF ONCOLOGY, ISSN: 0923-7534
Volume: 34, Pages: S1535-S1535 (1)
Conference
Annual Meeting of the European-Society-For-Medical-Oncology (Esmo), Date: DEC 01-03, 2023, Location: SINGAPORE
Indexing
Wos®
Google Scholar®
Publication Identifiers
Wos: WOS:001122475400157
Source Identifiers
ISSN: 0923-7534
Export Publication Metadata
Marked List
 Add to Marked List
Info
At this moment we don't have any links to full text documens.

A place for researchers and their institutions

Useful Links

Get Help

© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service